Utah Medical Products, Inc. Announces Quarterly Dividend
Utah Medical Products (Nasdaq:UTMD) has announced a quarterly cash dividend of $0.305 per share of common stock. The dividend will be payable on April 3, 2025, to stockholders of record at the close of business on March 14, 2025. This represents a 1.7% increase compared to the dividend declared in the same quarter of the previous year.
The company specializes in healthcare products for women and their babies, developing and manufacturing specialty medical devices that are recognized as standard equipment by clinicians in over 100 countries worldwide.
Utah Medical Products (Nasdaq:UTMD) ha annunciato un dividendo in contante trimestrale di $0.305 per azione di azioni ordinarie. Il dividendo sarà pagabile il 3 aprile 2025 agli azionisti registrati alla chiusura degli affari del 14 marzo 2025. Questo rappresenta un aumento dell'1,7% rispetto al dividendo dichiarato nello stesso trimestre dell'anno precedente.
La società è specializzata in prodotti sanitari per donne e i loro bambini, sviluppando e producendo dispositivi medici specializzati riconosciuti come attrezzature standard da clinici in oltre 100 paesi in tutto il mondo.
Utah Medical Products (Nasdaq:UTMD) ha anunciado un dividendo en efectivo trimestral de $0.305 por acción de acciones ordinarias. El dividendo se pagará el 3 de abril de 2025 a los accionistas registrados al cierre de operaciones el 14 de marzo de 2025. Esto representa un aumento del 1.7% en comparación con el dividendo declarado en el mismo trimestre del año anterior.
La empresa se especializa en productos de salud para mujeres y sus bebés, desarrollando y fabricando dispositivos médicos especializados que son reconocidos como equipamiento estándar por los clínicos en más de 100 países alrededor del mundo.
유타 메디컬 프로덕츠 (Nasdaq:UTMD)는 보통주 1주당 $0.305의 분기 현금 배당금을 발표했습니다. 배당금은 2025년 4월 3일에 지급되며, 2025년 3월 14일 영업 종료 시점의 주주에게 지급됩니다. 이는 지난해 같은 분기에 발표된 배당금에 비해 1.7% 증가한 금액입니다.
이 회사는 여성과 아기들을 위한 의료 제품을 전문으로 하여, 전 세계 100개국 이상에서 임상 전문가들에 의해 표준 장비로 인정받는 전문 의료 기기를 개발하고 제조합니다.
Utah Medical Products (Nasdaq:UTMD) a annoncé un dividende en espèces trimestriel de 0,305 $ par action d'actions ordinaires. Le dividende sera payable le 3 avril 2025 aux actionnaires enregistrés à la clôture des opérations le 14 mars 2025. Cela représente une augmentation de 1,7% par rapport au dividende déclaré au même trimestre de l'année précédente.
L'entreprise est spécialisée dans les produits de santé pour les femmes et leurs bébés, développant et fabriquant des dispositifs médicaux spécialisés reconnus comme équipements standards par les cliniciens dans plus de 100 pays à travers le monde.
Utah Medical Products (Nasdaq:UTMD) hat eine vierteljährliche Bardividende von $0,305 pro Aktie der Stammaktien angekündigt. Die Dividende wird am 3. April 2025 an die Aktionäre ausgezahlt, die am Ende des Geschäftstages am 14. März 2025 eingetragen sind. Dies stellt eine 1,7%ige Erhöhung im Vergleich zur im gleichen Quartal des Vorjahres erklärten Dividende dar.
Das Unternehmen ist auf Gesundheitsprodukte für Frauen und deren Babys spezialisiert und entwickelt sowie produziert medizinische Geräte, die von Klinikern in über 100 Ländern weltweit als Standardausrüstung anerkannt sind.
- Dividend increased by 1.7% year-over-year
- Quarterly dividend payment of $0.305 per share maintained
- Global market presence in over 100 countries
- None.
SALT LAKE CITY, UT / ACCESS Newswire / February 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.305) per share of common stock payable on April 3, 2025 to stockholders of record at the close of business on March 14, 2025. This is a
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.
Contact: Brian Koopman
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View the original press release on ACCESS Newswire
FAQ
What is the new quarterly dividend amount for UTMD stock?
When is UTMD's next dividend payment date?
What is the record date for UTMD's Q1 2025 dividend?
How much did UTMD increase its dividend compared to last year?
In how many countries are UTMD's medical devices recognized?
